IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 1 filers reported holding IMMUNOMEDICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $504,000 | +142.3% | 5,930 | +1.0% | 0.00% | +100.0% |
| Q2 2020 | $208,000 | -62.5% | 5,871 | -85.8% | 0.00% | -75.0% |
| Q1 2020 | $554,000 | -37.1% | 41,207 | -1.3% | 0.00% | -20.0% |
| Q4 2019 | $881,000 | +63.8% | 41,729 | +3.3% | 0.01% | +66.7% |
| Q3 2019 | $538,000 | -7.7% | 40,386 | -4.0% | 0.00% | 0.0% |
| Q2 2019 | $583,000 | -29.2% | 42,048 | -1.8% | 0.00% | -40.0% |
| Q1 2019 | $823,000 | +23.4% | 42,830 | -8.3% | 0.01% | 0.0% |
| Q4 2018 | $667,000 | -30.8% | 46,730 | +0.7% | 0.01% | -28.6% |
| Q3 2018 | $964,000 | -8.5% | 46,423 | +4.2% | 0.01% | -12.5% |
| Q2 2018 | $1,054,000 | +33.4% | 44,549 | -17.7% | 0.01% | +14.3% |
| Q1 2018 | $790,000 | -6.0% | 54,150 | +4.4% | 0.01% | 0.0% |
| Q4 2017 | $840,000 | +15.5% | 51,865 | +0.1% | 0.01% | +16.7% |
| Q3 2017 | $727,000 | +55.0% | 51,815 | -2.3% | 0.01% | +50.0% |
| Q2 2017 | $469,000 | +25.1% | 53,060 | -8.7% | 0.00% | 0.0% |
| Q1 2017 | $375,000 | +100.5% | 58,115 | +13.8% | 0.00% | +100.0% |
| Q4 2016 | $187,000 | +3.9% | 51,065 | -6.2% | 0.00% | 0.0% |
| Q3 2016 | $180,000 | +41.7% | 54,465 | +1.1% | 0.00% | 0.0% |
| Q2 2016 | $127,000 | -17.0% | 53,865 | -10.7% | 0.00% | – |
| Q1 2016 | $153,000 | -16.8% | 60,315 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $184,000 | +76.9% | 60,315 | +0.6% | 0.00% | +100.0% |
| Q3 2015 | $104,000 | -49.5% | 59,965 | +18.1% | 0.00% | -66.7% |
| Q2 2015 | $206,000 | – | 50,765 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|